Clinical Trials Browser

Phase 2 × Respiratory Tract Infections × Clear all

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

NCT04377659 2025-05-28

Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

Phase 2 Terminated

9 enrolled 8 charts

COVID-19, Respiratory Tract Infections

NCT01502072 2021-02-15

Respiratory Syncytial Virus - RSV Protocol

Phase 2 Completed

48 enrolled 11 charts

Neoplasms, Pneumonia, Respiratory Tract Infections, Respiratory Syncytial Virus Infections

Clinical Trials

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

Respiratory Syncytial Virus - RSV Protocol